Compass Therapeutics
Price & Volume
Stats
See moreOpen | $0.93 |
Previous Close | $0.90 |
Day Range | $0.82-$0.96 |
52W Range | $0.90-$6.88 |
Market Cap | $187.2M |
Shares Short | 41M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.39 |
News
See moreYahoo Finance • 9 days ago
Microsoft upgraded, HubSpot initiated: Wall Street's top analyst calls
Yahoo Finance • 10 days ago
Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug
Yahoo Finance • 10 days ago
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
Yahoo Finance • 2 months ago
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 39 |